ACRO BIOMEDICAL CO., LTD. Deferred Compensation Equity
ACRO BIOMEDICAL CO., LTD. (ACBM) had Deferred Compensation Equity of $0 as of 2023-12-31, per its 10-K filed 2025-07-18.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:DeferredCompensationEquity · last filed 2025-07-18
- 2023-12-31: Deferred Compensation Equity $0.00.
- 2023-09-30: Deferred Compensation Equity $0.00.
- 2023-06-30: Deferred Compensation Equity $1.01M.
- 2023-03-31: Deferred Compensation Equity $4.13M.
| Period end | Deferred Compensation Equity |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2025-07-18 |
| 2023-09-30 | $0.00 10-Q · filed 2025-07-11 |
| 2023-06-30 | $1.01M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $4.13M 10-Q · filed 2023-08-02 |
| 2022-12-31 | $8.06M 10-K · filed 2025-07-18 |
| 2022-09-30 | $11.99M 10-Q · filed 2022-11-21 |
| 2022-06-30 | $15.92M 10-Q · filed 2022-08-12 |
| 2021-12-31 | $23.77M 10-K · filed 2023-07-21 |